Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Mark Wilson/Getty Images

The White House and (almost all) Senate Republicans hope to confirm Mike Pompeo this week as Trump's new Secretary of State. But, according to multiple sources involved in the vote counting, Pompeo's fate is still not entirely certain with the Senate Foreign Relations Committee set to consider his nomination on Monday afternoon.

What we're hearing: Rand Paul remains a hard no, though White House Legislative Affairs Director Marc Short told me he thinks Paul's vote on Pompeo is still gettable, and refuses to give up trying. Short told me: "I still think it's hard for Rand Paul to explain to Kentucky voters how he voted 'yes' for John Kerry for Secretary of State and 'no' for Mike Pompeo."

  • Paul's deputy chief of staff Sergio Gor emailed me in response to Short's comment: "Senator Rand Paul remains a strong supporter of President Donald Trump's America First agenda. From cutting taxes to limiting our foreign interventions, there is a lot they both agree on. They remain friends and speak regularly."
  • Senate Republican leaders and the White House are still unsure whether Sen. Jeff Flake (R-AZ) will vote for Pompeo.
  • If Paul and Flake vote no, they'll need two red state Democrats to vote yes. They've already got Sen. Heidi Heitkamp (D-ND), and Republicans involved tell me they're optimistic about getting Joe Manchin (D-WV), Doug Jones (D-AL), and Joe Donnelly (D-IN).

Bottom line: The Pompeo confirmation process has been revealing — and has shown the White House how difficult it will be for Trump to get anybody confirmed should he fire any more cabinet secretaries. It was only a little over a year ago that the Senate voted 66-32 to confirm Pompeo as CIA chief; and now his vote is down to the wire.

Go deeper

3 hours ago - Health

Food banks feel the strain without holiday volunteers

People wait in line at Food Bank Community Kitchen on Nov. 25 in New York City. Photo: Michael Loccisano/Getty Images for Food Bank For New York City

America's food banks are sounding the alarm during this unprecedented holiday season.

The big picture: Soup kitchens and charities, usually brimming with holiday volunteers, are getting far less help.

5 hours ago - Health

AstraZeneca CEO: "We need to do an additional study" on COVID vaccine

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

AstraZeneca CEO Pascal Soriot said on Thursday the company is likely to start a new global trial to measure how effective its coronavirus vaccine is, Bloomberg reports.

Why it matters: Following Phase 3 trials, Oxford and AstraZeneca said their vaccine was 90% effective in people who got a half dose followed by a full dose, and 62% effective in people who got two full doses.

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: Coronavirus cases rose 10% in the week before Thanksgiving.
  2. Politics: Supreme Court backs religious groups on New York coronavirus restrictions.
  3. World: Expert says COVID vaccine likely won't be available in Africa until Q2 of 2021 — Europeans extend lockdowns.
  4. Economy: The winners and losers of the COVID holiday season.
  5. Education: National standardized tests delayed until 2022.